Page last updated: 2024-09-03

cimadronate and Angiogenesis, Pathologic

cimadronate has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amano, S; Inagaki, Y; Kikuchi, S; Ohno, S; Okamoto, T; Takeuchi, M; Yamagishi, S; Yoshimura, A	1

Other Studies

1 other study(ies) available for cimadronate and Angiogenesis, Pathologic

Article	Year
Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro. Biochemical and biophysical research communications, 2002, Sep-20, Volume: 297, Issue:2 Topics: Animals; Cells, Cultured; Diphosphonates; Endothelial Growth Factors; Endothelium, Vascular; Flavonoids; Glycation End Products, Advanced; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Neovascularization, Pathologic; NF-kappa B; Polyisoprenyl Phosphates; Promoter Regions, Genetic; Sesquiterpenes; Transcription Factor AP-1; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2002

Article

Year

Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro.

Biochemical and biophysical research communications, 2002, Sep-20, Volume: 297, Issue:2

Topics: Animals; Cells, Cultured; Diphosphonates; Endothelial Growth Factors; Endothelium, Vascular; Flavonoids; Glycation End Products, Advanced; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Neovascularization, Pathologic; NF-kappa B; Polyisoprenyl Phosphates; Promoter Regions, Genetic; Sesquiterpenes; Transcription Factor AP-1; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2002